Jmd Properties Inc

Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer

Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting

Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting

Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards